Health Policy Conference Centre for Health Services and Policy Research Scientific Innovation, The Economy, and Health Eliot A. Phillipson President and CEO Canada Foundation for Innovation February, 2009 www.innovation.ca
Role of Government in Making Canada Competitive on the World Stage 1997 2007 2007 going forward
1997 A TURNING POINT IN CANADA federal budget surpluses the innovation agenda
CHARACTERISTICS OF INNOVATIVE REGIONS/SOCIETIES cutting-edge research and development enterprise highly-educated and skilled workforce business, regulatory, and social environment that encourages entrepreneurship and creative thinking
1997 A TURNING POINT IN CANADA federal budget surpluses the innovation agenda akey strategy: invest in higher education research
$2,500 $2,000 Federal R&D Funding by Sector Intramural Govt Science illions) ($ M $1,500 $1,000 Higher Education $500 Business $0 199292 199393 199494 199595 199696 199797 199898 1999 2000 200101 200202 200303 200404 Source: Statistics Canada, Sciences Statistics, Vol. 30, No 6, September 2006
UNIVERSITY RESEARCH IN CANADA circa 1997 Challenge deficit in infrastructure Solution Canada Foundation for Innovation Investment $400M/yr the brain drain rising indirect costs of research Canada Research Chairs Program Indirect Costs Program $300M/yr $300M/yr
Prov vincial le evel University research Canadian scene Researchers and Students Institutions Themes Federal level Granting Councils: NSERC SSHRC CIHR NCE Canada Research Chairs Canada Foundation for Innovation Indirect costs Genome Canada Climate and Atmosph. Res. Sustainable Dev. University facilities and services Direct costs of research (Councils, foundations and government programs)
GOVERNMENT EXPENDITURES ON R&D % GDP 0.9 0.8 0.7 0.6 05 0.5 0.4 0.3 0.2 0.1 0 OECD 2006 Can Fr Ger Jap U.S. U.K. Italy
HIGHER EDUCATION R&D %GDP OECD Main Science and Technology Indicators, 2007 www.innovation.ca
GENERAL EXPENDITURES ON R&D % GDP OECD 2006 4.5 4 3.5 3 25 2.5 2 1.5 1 0.5 0 Isr Switz Kor US Fr Can
% 80 70 60 50 R&D EXPENDITURES BY FUNDING SECTOR 40 Industry 30 20 10 0 Kor Isr Switz US OECD Can Govt OECD 2007
% 80 70 60 50 40 30 20 10 0 R&D EXPENDITURES BY PERFORMING SECTOR Kor Isr Switz US OECD Can Industry Govt Higher Ed OECD 2007
R&D EXPENDITURES IN HEALTH BY PERFORMING SECTOR Statistics Canada 2007
CITATION OF S&E PUBLICATIONS Country All Citations Top 1% (% world share)* (% world share)** United States 42 63 United Kingdom 8 13 Japan 7 7 Germany 7 10 France 5 7 Canada 4 6 * National Science Board Science & Engineering Indicators, 2006 ** D King, The Scientific Impact of Nations, Nature 2004, 430:311-316
Medical Research Publications, 1996-2006 (Mean Number of Citations per Publication) SCImago Journal & Country Rank
Medical Research Publications, 1996-2006 (H Index) SCImago Journal & Country Rank
Origin of Researchers Recruited to Canadian Institutions, 2003-2008* 2008* Other countries, 19% United States, 20% Canada, 61% * recruitment facilitated by availability of recruitment facilitated by availability of CFI-funded infrastructure; n = 7060
Role of Government in Making Canada Competitive on the World Stage 1997 2007 2007 going forward
It is not the strongest of the species that survives, nor the most intelligent, but the one most responsive to change. Charles Darwin
THE CHANGING RESEARCH ENVIRONMENT increasingly competitive increasingly strategic at national and regional levels increasingly collaborative across disciplines, sectors, and jurisdictions enhanced focus on outcomes and benefits
GOVERNMENT OF CANADA S&T STRATEGY Mobilizing i Science and Technology to Canada s Advantage Core Principles promoting world class excellence focusing on priorities encouraging partnerships enhancing accountability
THE RETURN ON INVESTMENT IN HEALTH R&D academic sector publications, citations, patents; recruitment and retention of HQP private sector added value health care industry efficiencies, ce ces, improved safety patients, public cures, enhanced quality of life governments economic and social benefits
CONCLUSIONS Government has played a critical role in the past decade in enhancing Canada s S&T competitiveness. Canada is competing well in the changing research environment, but continuing adaptation ti will be required. There is reason for optimism, but no room for complacency.
www.innovation.ca thank you! merci! www.innovation.ca